Impact of concomitant medication use on belimumab efficacy and safety in patients with systemic lupus erythematosus

A Retrospective Administrative Claims Database Evaluation of the Utilization of Belimumab in US Managed Care Settings

(2015) Xuehua Ke et al.   CLINICAL THERAPEUTICS

Treatment Algorithms in Systemic Lupus Erythematosus

(2015) Chayawee Muangchan et al.   ARTHRITIS CARE & RESEARCH

Belimumab in systemic lupus erythematosus: a perspective review

(2015) Joyce S. Hui-Yuen et al.   Therapeutic Advances in Musculoskeletal Disease

Disease Control and Safety of Belimumab Plus Standard Therapy Over 7 Years in Patients with Systemic Lupus Erythematosus

(2013) E. M. Ginzler et al.   JOURNAL OF RHEUMATOLOGY

Belimumab in the treatment of systemic lupus erythematosus: high disease activity predictors of response

(2012) Ronald F van Vollenhoven et al.   ANNALS OF THE RHEUMATIC DISEASES

A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus

(2011) Richard Furie et al.   ARTHRITIS AND RHEUMATISM

Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial

(2011) Sandra V Navarra et al.   LANCET

Novel evidence-based systemic lupus erythematosus responder index

(2009) Richard A. Furie et al.   ARTHRITIS AND RHEUMATISM

The role of B lymphocyte stimulator (BLyS) in systemic lupus erythematosus

(2009) Michael P. Cancro et al.   JOURNAL OF CLINICAL INVESTIGATION

Systemic Lupus Erythematosus

(2008) Anisur Rahman et al.   NEW ENGLAND JOURNAL OF MEDICINE